Table 2. Treatment characteristics.

		OVERALL	mEHT	Control	P Value (t-test)
	n	206	104 [50.5%]	102 [49.5%]
Total radiation dose	Mean	84.3Gy	84.7Gy	84Gy	p = 0.624
	SD	9.55	7.65	11.18
	Range	2-86Gy	20-86Gy	2-86Gy
Total external beam radiation	Mean	48.2Gy	49.4Gy	48.0Gy	p = 0.724
	SD	8.47	7.74	9.19
	Range	2-50Gy	20-86Gy	2-50Gy
Days to complete all RT	Mean	41.79	41.46	42.13	P = 0.560
	SD	8.16	5.88	9.98
	Range	0–97 days	12–65 days	0–97 days
No of Cisplatin doses	Mean	1.31	1.38	1.25	p = 0.179
	SD	0.69	0.67	0.58
	0	27 [13%]	11 [11%]	16 [16%]
	1	88 [43%]	43 [41%]	45 [44%]
	2	91 [44%]	50 [48%]	41 [40%]
	Mean	2.88	2.89	2.87	p = 0.778
	SD	0.55	0.52	0.58
No of brachytherapy fractions	0	2 [1%]	1 [1%]	1 [1%]
	1	2 [1%]	0 [0%]	2 [3%]
	2	4 [2%]	3 [4%]	1 [1%]
	3	198 [95%]	100 [95%]	98 [95%]
No of mEHT doses	Mean		9.09
	SD		2.07
	Range		1–10
Average administered (KJ)	Mean		369.32KJ
	SD		71.06
	Range		237- 429KJ

Abbreviations: mEHT: Modulated electro-hyperthermia; SD: Standard Deviation; RT: Radiotherapy; KJ: Kilojoules.